NBI™ (Narrow Band Imaging™) Technology for Urology

NBI™ (Narrow Band Imaging™) technology is the world’s only patented endoscopic light technology that enables effective targeting of bladder tumor biopsies not seen under white light without the need for dyes or drugs.

NBI™ (Narrow Band Imaging™) technology enables improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients. NBI™ (Narrow Band Imaging™) technology should not be intended to replace histopathological sampling as a means of diagnosis.

• Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: A systematic review and meta-analysis study summary
• A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences study summary
• Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer study summary
• NBI™ (Narrow Band Imaging™) technology cystoscopy and bipolar plasma vaporization for large non-muscle-invasive bladder tumors–results of a prospective, randomized comparison to the standard approach
• NBI™ (Narrow Band Imaging™) technology cystoscopy improves the detection of non-muscle-invasive bladder cancer
• NBI™ (Narrow Band Imaging™) technology for detecting residual/recurrent cancerous tissue during second transurethral resection of newly-diagnosed non-muscle-invasive high-grade bladder cancer
• Applying NBI™ (Narrow Band Imaging™) technology in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder
• NBI™ (Narrow Band Imaging™) technology flexible cystoscopy in the detection of primary non-muscle-invasive bladder cancer: a ”second look” matters?